Seeking Men and Women 18 years or older who have completed a Gilead sponsored filgotinib parent study for RA GS-US-417-0303 for the treatment of Rheumatoid Arthritis (RA),
The purpose of this study is to see if filgotinib (study drug) can be safe and useful in the long-term treatment of Rheumatoid Arthritis.
What we're hoping for
The results and information obtained from this study may help others in the future.
ClinicalTrials.gov Identifier: NCT03025308